Literature DB >> 23131748

Myelination: do astrocytes play a role?

Susan C Barnett1, Christopher Linington.   

Abstract

Astrocytes are the most abundant cell type in the adult central nervous system (CNS), and their functional diversity in response to injury is now being appreciated. Astrocytes have long been considered the main player in the inhibition of CNS repair via the formation of the gliotic scar, but now it is accepted that astrocyte can play an important role in CNS repair and remyelination. Interest in the relationship between astrocytes and myelination focused initially on attempts to understand how the development of plaques of astroglial scar tissue in multiple sclerosis was related to the failure of these lesions to remyelinate. It is now considered that this is an end stage pathological response to injury, and that normally astrocytes play important roles in supporting the development and maintenance of CNS myelin. This review will focus on how this new understanding may be exploited to develop new strategies to enhance remyelination in multiple sclerosis and other diseases.

Entities:  

Keywords:  CNS; astrocytes; myelination; phenotypes

Mesh:

Year:  2012        PMID: 23131748     DOI: 10.1177/1073858412465655

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  35 in total

1.  TIMP-1 couples RhoK activation to IL-1β-induced astrocyte responses.

Authors:  Kasey M Johnson; Stephen J Crocker
Journal:  Neurosci Lett       Date:  2015-10-17       Impact factor: 3.046

2.  Endocytotic potential governs magnetic particle loading in dividing neural cells: studying modes of particle inheritance.

Authors:  Jacqueline A Tickle; Stuart I Jenkins; Boris Polyak; Mark R Pickard; Divya M Chari
Journal:  Nanomedicine (Lond)       Date:  2016-01-20       Impact factor: 5.307

3.  Prolonged stimulation of a brainstem raphe region attenuates experimental autoimmune encephalomyelitis.

Authors:  Pernille M Madsen; Stephanie S Sloley; Alberto A Vitores; Melissa M Carballosa-Gautam; Roberta Brambilla; Ian D Hentall
Journal:  Neuroscience       Date:  2017-01-29       Impact factor: 3.590

4.  Inhibitors of myelination: ECM changes, CSPGs and PTPs.

Authors:  Danielle E Harlow; Wendy B Macklin
Journal:  Exp Neurol       Date:  2013-11-04       Impact factor: 5.330

5.  Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination.

Authors:  Evelien Houben; Kris Janssens; Doryssa Hermans; Jennifer Vandooren; Chris Van den Haute; Melissa Schepers; Tim Vanmierlo; Ivo Lambrichts; Jack van Horssen; Veerle Baekelandt; Ghislain Opdenakker; Wia Baron; Bieke Broux; Helena Slaets; Niels Hellings
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

6.  Glucocorticoid-Induced Reductions of Myelination and Connexin 43 in Mixed Central Nervous System Cell Cultures Are Prevented by Mifepristone.

Authors:  José Javier Miguel-Hidalgo; Kathleen Carter; Preston Hardin Deloach; Leon Sanders; Yi Pang
Journal:  Neuroscience       Date:  2019-06-01       Impact factor: 3.590

7.  Neonatal infraorbital nerve crush-induced CNS synaptic plasticity and functional recovery.

Authors:  Fu-Sun Lo; Shuxin Zhao; Reha S Erzurumlu
Journal:  J Neurophysiol       Date:  2014-01-29       Impact factor: 2.714

Review 8.  Role of astrocytic glutamate transporter in alcohol use disorder.

Authors:  Jennifer R Ayers-Ringler; Yun-Fang Jia; Yan-Yan Qiu; Doo-Sup Choi
Journal:  World J Psychiatry       Date:  2016-03-22

9.  The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease.

Authors:  Alexandra Badea; Lauren Kane; Robert J Anderson; Yi Qi; Mark Foster; Gary P Cofer; Neil Medvitz; Anne F Buckley; Andreas K Badea; William C Wetsel; Carol A Colton
Journal:  Neuroimage       Date:  2016-08-10       Impact factor: 6.556

Review 10.  White matter astrocytes in health and disease.

Authors:  I Lundgaard; M J Osório; B T Kress; S Sanggaard; M Nedergaard
Journal:  Neuroscience       Date:  2013-11-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.